QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Subsequent Events

Subsequent Events	3 Months Ended
Mar. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	NOTE 12 - SUBSEQUENT EVENTS In May 2018, the Board authorized and the Company commenced a follow-on round to its 2017 Bridge Offering (the “Bridge Follow-On”) in an amount of up to $300,000. The terms of this Bridge Follow-On round are identical to the 2017 Bridge Offering except the notes will have a two-year term (instead of three). As of May 15, 2018, the Company raised $40,000 from two Directors and one Board observer. Funds from this offering will be used for general working capital.

Subsequent Events

3 Months Ended

Mar. 31, 2018

Subsequent Events [Abstract]

Subsequent Events

NOTE 12 - SUBSEQUENT EVENTS

In May 2018, the Board authorized and the Company commenced a follow-on round to its 2017 Bridge Offering (the “Bridge Follow-On”) in an amount of up to $300,000. The terms of this Bridge Follow-On round are identical to the 2017 Bridge Offering except the notes will have a two-year term (instead of three). As of May 15, 2018, the Company raised $40,000 from two Directors and one Board observer. Funds from this offering will be used for general working capital.